VPRIV

DRUG2 trials

Sponsors

Shaare Zedek Medical Center

Conditions

Gaucher Disease, Type 1Primary Disease

Phase 4

Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease

CompletedNCT03702361

Shaare Zedek Medical CenterPrimary Disease

Start: 2018-09-04End: 2021-03-18Updated: 2021-03-19

Long Term Impact of Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV)

CompletedNCT04120506

Shaare Zedek Medical CenterGaucher Disease, Type 1

Start: 2016-01-10End: 2022-01-01Updated: 2022-10-28